Clinical Trial 23422

• Overview

  Study Title:

  Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel

  Objective:

  Primary: To collect long-term follow-up data on delayed adverse events after administration of cilta-cel, and to characterize and understand the long-term safety profile of cilta-cel. Secondary: To collect additional long-term data on replication competent lentivirus (RCL), cilt-cel persistence, efficacy and overall survival

• Treatments

  Therapies:

  Cell Therapy

  Medications:

  Not Applicable ()

• Inclusion Criteria

  Key Inclusion Criteria:
  • Subjects who have received at least one dose of cilta-cel in a Company-sponsored clinical study.
  • Subjects who have provided informed consent for Study MMY4002.

• Exclusion Criteria

  Key Exclusion Criteria:
  • No exclusion criteria are applicable in this study.

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.